Home › Funds › Fore Capital, LLC › EVO
Fore Capital, LLC position in EVO
EVOTEC AG · Health Care
Fore Capital, LLC reported holding 51,355 shares of EVO (EVOTEC AG) in its Q3 2026 13F filing — a position valued at US$88K, representing 0.04% of its reported portfolio and ranking #42 among its reported holdings. Fore Capital, LLC has disclosed EVO holdings in 5 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Fore Capital, LLC's EVO position evolved
Fore Capital, LLC first disclosed a stake in EVO in Q1 2025 at 17,005 shares (US$57K). The position peaked in Q4 2025 at 31,355 shares, worth US$97K. Across 5 filings, Fore Capital, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 51,355 shares valued at US$88K — an increase of 20,000 shares quarter over quarter.. Notable position changes include a 64% increase in Q3 2026 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 17.00K | $56.80K | New |
| Q4 2025 | 31.36K | $96.57K | New |
| Q1 2026 | 31.36K | $78.39K | Hold |
| Q2 2026 | 31.36K | $87.79K | Hold |
| Q3 2026 | 51.35K | $87.82K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EVO and 13F data
EVO (EVOTEC AG) is a Health Care company. 22 other funds we track also report a position in EVO — the largest reported positions include DCF Advisers, LLC (US$1.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Fore Capital, LLC
FAQ
How long has Fore Capital, LLC held EVO?
Fore Capital, LLC has disclosed EVO holdings in 5 of the last 7 reported quarters, going back to Q1 2025.
What is Fore Capital, LLC's current position in EVO?
As of Q3 2026, Fore Capital, LLC holds 51.35K shares of EVO (EVOTEC AG), valued at $87.82K, representing 0.04% of its reported portfolio and ranking #42.
Has Fore Capital, LLC been buying or selling EVO?
In the latest 13F filing (Q3 2026), Fore Capital, LLC increased its position in EVO. The position peaked in Q4 2025 at 31.36K shares.
Which other funds hold EVO?
Other major institutional holders of EVO include DCF Advisers, LLC, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.